Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Aclipse Therapeutics Logo
Aclipse Therapeutics Growth Score
56
CB Rank
92383
Heat Score
59
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Founded
obfuscation
PrivateGrant Radnor, Pennsylvania, United States1-10 www.aclipsetherapeutics.com/
Biotechnology
Medical
Pharmaceutical
Overview

Aclipse Therapeutics
Total Funding
obfuscation
Growth Score
56
Heat Score
59

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score56
-4 pts
in past quarter
Heat Score 59
-15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Aclipse Therapeutics

CB Rank
92383
Aclipse Therapeutics focuses on developing differentiated drugs to address diseases with unmet medical needs.
Founded
obfuscation
PrivateGrant Radnor, Pennsylvania, United States1-10 www.aclipsetherapeutics.com/
Biotechnology
Medical
Pharmaceutical

Funding Rounds

Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

  • Photo of Raymond K. Houck
    Raymond K. Houck: CEO and Co-founder
    Past Role: Automated Call Processing Corporation, President and CEO
  • Photo of Ning Shan
    Ning Shan: Chief Scientific Officer and Co-founder

Details

Legal Name Aclipse Therapeutics LLC
Operating Status Active
Company Type For Profit
Founders  Ning Shan, Raymond K. Houck
About the Company

Aclipse Therapeutics is a biopharmaceutical company that focuses on developing differentiated drugs to address diseases with unmet medical needs. Its strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel drug molecule that inhibits these pathways, allowing us to build upon

existing nonclinical and clinical data while creating a significant patent barrier-to-entry.

Contact Email info@aclipsetherapeutics.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Growth Insight

Products & Services

M102
An orally administered small molecule drug candidate activating NRF2 and HSF1 pathways to address multiple ALS disease mechanisms.
M107
An oral small molecule PPARγ activator targeting gastroparesis by modulating macrophage phenotypes to reduce stomach inflammation and improve gastric function.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant
obfuscation
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
1
obfuscation
U.S. Department of DefenseGrant

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
—
U.S. Department of Defense Logo
U.S. Department of Defense
Yes
Grant - Aclipse Therapeutics Logo
Grant - Aclipse Therapeutics
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 4

Employee Profiles

News

News and Press

News•Nov 5, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Sep 14, 2023
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

191
-39.56%
 in past month

IT Spend

$67.7KThis year, Aclipse Therapeutics is projected to spend $67.7K on IT, according to Aberdeen.

Active Website Tech Count

2Aclipse Therapeutics is actively using 2 technologies for its website, according to BuiltWith. These include Viewport Meta and  CommonCrawl Top 10m.
Sub-Organizations
Frequently Asked Questions

Where is Aclipse Therapeutics's headquarters? Aclipse Therapeutics is located in Radnor, Pennsylvania, United States.Who invested in Aclipse Therapeutics? Aclipse Therapeutics has 5 investors including U.S. Department of Defense and  Medical Research Council.When was the last funding round for Aclipse Therapeutics? Aclipse Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Aclipse Therapeutics's competitors? Alternatives and possible competitors to Aclipse Therapeutics may include Mayo Clinic, Amylyx Pharmaceuticals, and  Vertex Pharmaceuticals.How much funding has Aclipse Therapeutics raised to date? Aclipse Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(55a1db1 1)
|